Business Context and Reporting Period
This Form 8-K was filed by Anthem, Inc. (now Elevance Health, Inc.) on November 20, 2015. The report serves as a Regulation FD disclosure regarding upcoming investor communications scheduled between December 2, 2015, and December 7, 2015. The filing primarily updates full-year 2015 financial guidance and reiterates forward-looking risks.
Key Financial Metrics
The filing provides specific per-share earnings guidance for the full year 2015 but does not report total revenue, cash flow, debt, or liquidity figures in this document.
- Full-Year 2015 GAAP Net Income Guidance: $9.53 to $9.63 per share.
- Unfavorable Items: Approximately $0.57 per share included in the GAAP range.
- Full-Year 2015 Adjusted Net Income Guidance: $10.10 to $10.20 per share (excluding unfavorable items).
Material Changes and Operational Updates
Management noted that the commercial individual business tracked expectations in October, supporting the current full-year outlook. The guidance remains unchanged from the third quarter 2015 earnings release, with no new adjustments reported beyond those previously disclosed.
Guidance, Outlook, and Risks
Management maintains its earnings outlook for 2015. The filing includes an extensive Safe Harbor statement detailing risks that could cause actual results to differ from projections. Key risks and contingencies include:
- Regulatory Environment: Impacts of the Affordable Care Act, health care reform, and government participation in managed care.
- Acquisition Risks: Uncertainties regarding the pending acquisition of Cigna Corporation, including regulatory approvals, shareholder votes, integration challenges, and synergy realization.
- Market and Operational Risks: Health care cost trends, premium rate adequacy, enrollment changes, and competition.
- Cybersecurity: Ongoing impacts and investigations related to the cyber attack reported in February 2015.
- Financial Risks: Potential impairment of intangible assets, credit rating downgrades, and liquidity constraints related to indebtedness.
Investor Verification Checklist
- Verify the final full-year 2015 earnings report to confirm if actual results fall within the $9.53-$9.63 GAAP and $10.10-$10.20 adjusted per-share ranges.
- Monitor regulatory updates regarding the proposed acquisition of Cigna Corporation, specifically approval status and potential deal termination risks.
- Review subsequent filings for developments related to the February 2015 cyber attack and associated litigation or financial penalties.
- Assess the performance of the commercial individual business segment in the fourth quarter to validate the October tracking mentioned in this filing.